{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9667966", "DateCompleted": {"Year": "1998", "Month": "08", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "17"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0022-2623", "JournalIssue": {"Volume": "41", "Issue": "15", "PubDate": {"Year": "1998", "Month": "Jul", "Day": "16"}}, "Title": "Journal of medicinal chemistry", "ISOAbbreviation": "J Med Chem"}, "ArticleTitle": "Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta.", "Pagination": {"StartPage": "2754", "EndPage": "2764", "MedlinePgn": "2754-64"}, "Abstract": {"AbstractText": ["Cryptolepine (1) is a rare example of a natural product whose synthesis was reported prior to its isolation from nature. In the previous paper we reported the discovery of cryptolepine's antihyperglycemic properties. As part of a medicinal chemistry program designed to optimize natural product lead structures originating from our ethnobotanical and ethnomedical field research, a series of substituted and heterosubstituted cryptolepine analogues was synthesized. Antihyperglycemic activity was measured in vitro and in an NIDDM mouse model to generate the first structure-bioactivity study about the cryptolepine nucleus."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shaman Pharmaceuticals, Inc., 213 East Grand Avenue, South San Francisco, California 94080, USA. dbierer@shaman.com"}], "LastName": "Bierer", "ForeName": "D E", "Initials": "DE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Dubenko", "ForeName": "L G", "Initials": "LG"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zhang", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lu", "ForeName": "Q", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Imbach", "ForeName": "P A", "Initials": "PA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Garofalo", "ForeName": "A W", "Initials": "AW"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Phuan", "ForeName": "P W", "Initials": "PW"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Fort", "ForeName": "D M", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Litvak", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gerber", "ForeName": "R E", "Initials": "RE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sloan", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Luo", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cooper", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Reaven", "ForeName": "G M", "Initials": "GM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Chem", "NlmUniqueID": "9716531", "ISSNLinking": "0022-2623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Indole Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Indoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolines"}, {"RegistryNumber": "480-26-2", "NameOfSubstance": "cryptolepine"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "3T3 Cells"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Adipose Tissue"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Biological Transport"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["blood"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glucose"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Indole Alkaloids"}, {"QualifierName": [], "DescriptorName": "Indoles"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Obese"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Quinolines"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "7", "Day": "21"}, {"Year": "1998", "Month": "7", "Day": "21", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "7", "Day": "21", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9667966", "10.1021/jm970735n", "jm970735n"]}}]}